aristolochic acid i has been researched along with 2,4,6-trimethyl-n-(meta-3-trifluoromethylphenyl)benzenesulfonamide in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, FA; Jan, CR; Kuo, CC; Kuo, DH; Shieh, P; Tsai, JY | 1 |
1 other study(ies) available for aristolochic acid i and 2,4,6-trimethyl-n-(meta-3-trifluoromethylphenyl)benzenesulfonamide
Article | Year |
---|---|
Effect of m-3M3FBS on Ca²⁺ movement in PC3 human prostate cancer cells.
Topics: Adenocarcinoma; Aristolochic Acids; Calcium; Calcium Channel Blockers; Calcium Signaling; Cell Line, Tumor; Dose-Response Relationship, Drug; Endoplasmic Reticulum; Humans; Indoles; Male; Models, Animal; Phospholipase A2 Inhibitors; Prostatic Neoplasms; Sulfonamides; Thapsigargin; Type C Phospholipases | 2010 |